Author:
Schwartz Jules I.,De Smet Marina,Larson Pat J.,Verbesselt R.,Ebel David L.,Lins Robert,Lens Simonne,Porras Arturo G.,Gertz Barry J.
Subject
Pharmacology (medical),Pharmacology
Reference28 articles.
1. Rofecoxib [Vioxx, MK-0966; 4-(4′-Methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor: pharmacological and biochemical profiles;Chan;J Pharmacol Exp Ther,1999
2. Selective inhibition of the cyclooxygenase-2 isoform: evaluation of analgesic response in patients following third molar extraction;Ehrich;Clin Pharmacol Ther,1999
3. Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans;Depré;Euro J Clin Pharm,2000
4. Selective inhibition of cyclooxygenase type-2 reverses endotoxin-induced fever in monkeys and naturally occurring fever in humans;Schwartz;Clin Pharmacol Ther,1999
5. Human cyclooxygenase-2 cDNA;Hla;Proc Natl Acad Sci USA,1992
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献